NICE backs NHS use of Novartis’ cholesterol drug Leqvio
pharmaphorum
SEPTEMBER 1, 2021
. “The obvious disappointment is that they don’t seem to have thought it cost effective for familial hypercholesterolaemia (FH), where patients have genetically elevated LDL-C and limitations on treatments available. This needs further thought,” he added.
Let's personalize your content